Skip to Main Content

Prevention of Stroke and Dementia in Primary Care (INVADE)

This study has been terminated.

Sponsor:

Collaborators:

Allgemeine Ortskrankenkasse Bayern (AOK)

Stiftung Deutsche Schlaganfall-Hilfe

Ratiopharm

Sanofi-Synthelabo

Organon

Teva Pharma GmbH

Bayer

Berlin-Chemie Menarini

Information provided by:

Technische Universität München

ClinicalTrials.gov Identifier:

NCT01107548

First received: April 19, 2010

Last updated: February 16, 2012

Last verified: April 2010

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been terminated.
Study Completion Date:	March 2010
Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)

Publications:

Scherpinski U, Bickel H, Gnahn H, Förstl H, Conrad B, Sander D. [Intervention project on cerebrovascular diseases and dementia in the Ebersberg district (INVADE): rationale and design] Nervenarzt. 2002 Dec;73(12):1199-204. German.

Sander D, Schulze-Horn C, Bickel H, Gnahn H, Bartels E, Conrad B. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Stroke. 2006 Feb;37(2):351-7. Epub 2005 Dec 22.

Sander K, Bickel H, Schulze Horn C, Huntgeburth U, Poppert H, Sander D. [Peripheral arterial disease: predictors and treatment intensity. Two-years of data from the population-based INVADE project] Dtsch Med Wochenschr. 2008 Mar;133(10):455-9. German.